Common Contracts
2 similar License Agreement contracts by Amag Pharmaceuticals Inc., Palatin Technologies Inc
LICENSE AGREEMENT by and between AMAG PHARMACEUTICALS, INC. and PALATIN TECHNOLOGIES, INC. January 8, 2017License Agreement • February 10th, 2017 • Palatin Technologies Inc • Pharmaceutical preparations • New York
This License Agreement (the “Agreement”) is entered into as of January 8, 2017 (the “Execution Date”), by and between AMAG Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at 1100 Winter Street, Waltham, MA 02451 (“AMAG”) and Palatin Technologies, Inc., a corporation organized and existing under the laws of Delaware and having a principal place of business at 4-B Cedar Brook Drive, Cedar Brook Corporate Center, Cranbury, NJ 08512 (“Palatin”). AMAG and Palatin may each be referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT by and between AMAG PHARMACEUTICALS, INC. and PALATIN TECHNOLOGIES, INC. January 8, 2017License Agreement • February 3rd, 2017 • Amag Pharmaceuticals Inc. • Pharmaceutical preparations • New York
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[…***…]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24B-2 PROMULGATED UNDER THE SECURITIES ACT OF 1934, AS AMENDED.
